Trial intelligence / Profile preview

Metformin for frozen shoulder and shoulder tendinopathy

ACTRN12616000629437Phase 3Recruiting

Sponsor
Northern Sydney Local Health District
Start
May 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in adhesive capsulitis (AC) and shoulder tendinopathy comparing Metformin with Placebo (2 arms). Primary endpoint: Proportion of participants with VAS pain score 2 or less out of 10 at 12 months. Started May 2017; status: recruiting.

02

Drugs

metformin
03

Conditions

adhesive capsulitis (AC)shoulder tendinopathy

Beyond the preview

Go deeper on ACTRN12616000629437.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12616000629437.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call